Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 164

Tests names and labsConditionsGenes and analytesMethods

CentoColon extended panel

Centogene AG - the Rare Disease Company
Germany
1917
  • C Sequence analysis of the entire coding region

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel - High Penetrance 16

Molecular Genetics Laboratory London Health Sciences Centre
Canada
2816
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Colorectal cancer, hereditary nonpolyposis type 1

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal cancer, hereditary nonpolyposis type 1

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lynch Syndrome via the MSH2 Exons 1-7 Inversion

PreventionGenetics
United States
11
  • T Targeted variant analysis

Prostate Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
2015
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Breast and Ovarian Cancer - Expanded and Lynch Syndrome Sequencing Panel with CNV Detection

PreventionGenetics
United States
2221
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Breast and Ovarian Cancer - High Risk and Lynch Syndrome Sequencing Panel with CNV Detection

PreventionGenetics
United States
1917
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Endometrial Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
1712
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Ovarian Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
3521
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

VistaSeq GYN Panel

Molecular Diagnostic Laboratory LabCorp
United States
1111
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

VisaSeq Breast and GYN Cancer Panel

Molecular Diagnostic Laboratory LabCorp
United States
3225
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
2717
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MSH2. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

PMS1. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

MSH6. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

MSH2. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

MLH1, MSH2. MLPA testing

Instituto de Medicina Genomica
Spain
32
  • D Deletion/duplication analysis

MLH1. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 164

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center